Report Detail
Global Sleep Disorder Treatment Drugs Market Insights, Forecast to 2025
- RnM2700335 |
- 17 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.
Factors such as increasing incidences of depression and other medical disorders, late night working schedule, busy lifestyle, lack of quality sleep, and rising geriatric population drive the market growth.
The global Sleep Disorder Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sleep Disorder Treatment Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Sleep Disorder Treatment Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sleep Disorder Treatment Drugs in these regions.
This research report categorizes the global Sleep Disorder Treatment Drugs market by top players/brands, region, type and end user. This report also studies the global Sleep Disorder Treatment Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Sanofi
Merck
GlaxoSmithKline
Koninklijke Philips
Takeda Pharmaceutical Company
Leva Pharmaceutical Industries
Cardinal Health
Becton Dickson and Company
Natus Medicalorporated
Market size by Product
Prescription-based Drugs
OTC Drugs
Herbal Drugs
Market size by End User
Hospitals
Clinics
Research Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sleep Disorder Treatment Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sleep Disorder Treatment Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sleep Disorder Treatment Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sleep Disorder Treatment Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sleep Disorder Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sleep Disorder Treatment Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sleep Disorder Treatment Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sleep Disorder Treatment Drugs Market Size Growth Rate by Product
- 1.4.2 Prescription-based Drugs
- 1.4.3 OTC Drugs
- 1.4.4 Herbal Drugs
- 1.5 Market by End User
- 1.5.1 Global Sleep Disorder Treatment Drugs Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Research Centers
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sleep Disorder Treatment Drugs Market Size
- 2.1.1 Global Sleep Disorder Treatment Drugs Revenue 2014-2025
- 2.1.2 Global Sleep Disorder Treatment Drugs Sales 2014-2025
- 2.2 Sleep Disorder Treatment Drugs Growth Rate by Regions
- 2.2.1 Global Sleep Disorder Treatment Drugs Sales by Regions
- 2.2.2 Global Sleep Disorder Treatment Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sleep Disorder Treatment Drugs Sales by Manufacturers
- 3.1.1 Sleep Disorder Treatment Drugs Sales by Manufacturers
- 3.1.2 Sleep Disorder Treatment Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Sleep Disorder Treatment Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Sleep Disorder Treatment Drugs Revenue by Manufacturers
- 3.2.1 Sleep Disorder Treatment Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Sleep Disorder Treatment Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Sleep Disorder Treatment Drugs Price by Manufacturers
- 3.4 Sleep Disorder Treatment Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Sleep Disorder Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sleep Disorder Treatment Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Sleep Disorder Treatment Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sleep Disorder Treatment Drugs Sales by Product
- 4.2 Global Sleep Disorder Treatment Drugs Revenue by Product
- 4.3 Sleep Disorder Treatment Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sleep Disorder Treatment Drugs Breakdown Data by End User
6 North America
- 6.1 North America Sleep Disorder Treatment Drugs by Countries
- 6.1.1 North America Sleep Disorder Treatment Drugs Sales by Countries
- 6.1.2 North America Sleep Disorder Treatment Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sleep Disorder Treatment Drugs by Product
- 6.3 North America Sleep Disorder Treatment Drugs by End User
7 Europe
- 7.1 Europe Sleep Disorder Treatment Drugs by Countries
- 7.1.1 Europe Sleep Disorder Treatment Drugs Sales by Countries
- 7.1.2 Europe Sleep Disorder Treatment Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sleep Disorder Treatment Drugs by Product
- 7.3 Europe Sleep Disorder Treatment Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Sleep Disorder Treatment Drugs by Countries
- 8.1.1 Asia Pacific Sleep Disorder Treatment Drugs Sales by Countries
- 8.1.2 Asia Pacific Sleep Disorder Treatment Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sleep Disorder Treatment Drugs by Product
- 8.3 Asia Pacific Sleep Disorder Treatment Drugs by End User
9 Central & South America
- 9.1 Central & South America Sleep Disorder Treatment Drugs by Countries
- 9.1.1 Central & South America Sleep Disorder Treatment Drugs Sales by Countries
- 9.1.2 Central & South America Sleep Disorder Treatment Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sleep Disorder Treatment Drugs by Product
- 9.3 Central & South America Sleep Disorder Treatment Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sleep Disorder Treatment Drugs by Countries
- 10.1.1 Middle East and Africa Sleep Disorder Treatment Drugs Sales by Countries
- 10.1.2 Middle East and Africa Sleep Disorder Treatment Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sleep Disorder Treatment Drugs by Product
- 10.3 Middle East and Africa Sleep Disorder Treatment Drugs by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Sleep Disorder Treatment Drugs Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Sanofi
- 11.2.1 Sanofi Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sanofi Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sanofi Sleep Disorder Treatment Drugs Products Offered
- 11.2.5 Sanofi Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Sleep Disorder Treatment Drugs Products Offered
- 11.3.5 Merck Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 Koninklijke Philips
- 11.5.1 Koninklijke Philips Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Koninklijke Philips Sleep Disorder Treatment Drugs Products Offered
- 11.5.5 Koninklijke Philips Recent Development
- 11.6 Takeda Pharmaceutical Company
- 11.6.1 Takeda Pharmaceutical Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Products Offered
- 11.6.5 Takeda Pharmaceutical Company Recent Development
- 11.7 Leva Pharmaceutical Industries
- 11.7.1 Leva Pharmaceutical Industries Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Products Offered
- 11.7.5 Leva Pharmaceutical Industries Recent Development
- 11.8 Cardinal Health
- 11.8.1 Cardinal Health Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Cardinal Health Sleep Disorder Treatment Drugs Products Offered
- 11.8.5 Cardinal Health Recent Development
- 11.9 Becton Dickson and Company
- 11.9.1 Becton Dickson and Company Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Products Offered
- 11.9.5 Becton Dickson and Company Recent Development
- 11.10 Natus Medicalorporated
- 11.10.1 Natus Medicalorporated Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Products Offered
- 11.10.5 Natus Medicalorporated Recent Development
12 Future Forecast
- 12.1 Sleep Disorder Treatment Drugs Market Forecast by Regions
- 12.1.1 Global Sleep Disorder Treatment Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sleep Disorder Treatment Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Sleep Disorder Treatment Drugs Market Forecast by Product
- 12.2.1 Global Sleep Disorder Treatment Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Sleep Disorder Treatment Drugs Revenue Forecast by Product 2019-2025
- 12.3 Sleep Disorder Treatment Drugs Market Forecast by End User
- 12.4 North America Sleep Disorder Treatment Drugs Forecast
- 12.5 Europe Sleep Disorder Treatment Drugs Forecast
- 12.6 Asia Pacific Sleep Disorder Treatment Drugs Forecast
- 12.7 Central & South America Sleep Disorder Treatment Drugs Forecast
- 12.8 Middle East and Africa Sleep Disorder Treatment Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sleep Disorder Treatment Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sleep Disorder Treatment Drugs . Industry analysis & Market Report on Sleep Disorder Treatment Drugs is a syndicated market report, published as Global Sleep Disorder Treatment Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sleep Disorder Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
